Z-Phe-Tyr(tBu)-diazomethylketone (CAS 114014-15-2)

Z-Phe-Tyr(tBu)-diazomethylketone is a chemical compound with diverse applications in scientific research and drug development. It is a modified peptide derivative consisting of the amino acids phenylalanine (Phe) and tyrosine (Tyr), along with a diazomethylketone functional group attached to the tyrosine residue. The tBu abbreviation indicates the presence of a tert-butyl group, which enhances stability and influences the compound′s properties. This compound is utilized as a selective inhibitor for proteolytic enzymes, particularly cysteine proteases. The diazomethylketone moiety acts as a reversible covalent inhibitor by specifically reacting with the active site of the target enzyme, irreversibly inhibiting its activity. The peptide sequence, Z-Phe-Tyr, plays a role in determining the selectivity and affinity of the compound towards specific proteases. Z-Phe-Tyr(tBu)-diazomethylketone is widely employed in biochemical and enzymatic studies to investigate the role of cysteine proteases in various biological processes, such as inflammation, apoptosis, and disease pathways. Its use in drug development focuses on designing therapeutic agents targeting specific protease-mediated diseases, including cancer, neurodegenerative disorders, and infectious diseases. The compound′s unique chemical structure and reactivity make it useful in understanding protease biology and developing novel therapeutic strategies. However, it is important to handle and use this compound with appropriate safety precautions due to its reactive nature and potential hazards associated with handling diazomethylketones.